Antibody-induced erythrophagocyte reprogramming of Kupffer cells prevents anti-CD40 cancer immunotherapy-associated liver toxicity.
Marc PfefferléIrina L DubachRaphael M BuzziElena DürstNadja Schulthess-LutzLivio BaselgiaKerstin HansenLarissa ImhofSandra KoernigDidier Le RoyThierry RogerRok HumarDominik J SchaerFlorence VallelianPublished in: Journal for immunotherapy of cancer (2023)
Our study offers a targeted approach to uncouple CD40-augmented antitumor immunity in peripheral tissues from harmful inflammatoxicity in the liver.